middle.news

How Algorae’s AI Platform and Pipeline Are Narrowing Losses in 2025

2:56am on Saturday 30th of August, 2025 AEST Healthcare
Read Story

How Algorae’s AI Platform and Pipeline Are Narrowing Losses in 2025

2:56am on Saturday 30th of August, 2025 AEST
Key Points
  • 13% increase in total revenue and other income to $141,050
  • 62% reduction in net loss after tax to $802,958
  • Launch and validation of AlgoraeOS AI drug discovery platform
  • Positive preclinical results for dementia and cardiovascular drug candidates
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Algorae Pharmaceuticals (ASX:1AI)
OPEN ARTICLE